1
Curriculum Vitae
Name: Amitis Ramezani
Address: Clinical Research Department, Pasteur Institute of Iran, No. 69, Pasteur Ave.,
Tehran 1316943551, Iran
Tel: (+98-21) 6696 8852
Fax: (+98-21) 66465147
E-mail: [email protected]
Education
• Infectious Disease Specialist. Tehran University of Medical Sciences
• MPH. Faculty of Health, Tehran University of Medical Sciences
Associations/Membership
• Editorial Board of Iranian Journal of Infectious Diseases and Tropical
Medicine
• Editorial Board of Gastroenterology and Hepatology research
• Regional Editor of Asian Journal of Medical Sciences
• Editorial Board of Hepatitis Monthly
• Member of the Board of Iranian Society for Support of Patients with
Infectious Diseases and Tropical Medicine
• Member of the Board of Infectious Diseases Society
• Member of the Board of Pediatric Infectious Disease Research Center of
Tehran University of Medical Sciences
2
• Permanent Member of Infectious Disease and Tropical Medicine Research
Center of Shaheed Beheshti Medical Sciences University
• Member of International AIDS Society (IAS)
• Member of International Society for Infectious Diseases (ISID)
• Member of European Society of Clinical Microbiology and Infectious Diseases
(ESCMID)
• Member of Nosocomial Infection, Vaccination, HIV, Hepatitis, Tuberculosis,
IT Committee of Infectious Research Center of Shaheed Beheshti University
• Member of Scientific Executive Committee of Iranian Infectious Diseases
Conferences (9th-21st)
• Member of Scientific Executive Committee of The first annual AIDS research
congress of Iran. 2007
• Scientific Executive Committee of National Iranian Congress of Brucellosis 5-
6 July 2005
• Scientific Executive Committee of Hepatitis B Seminar Held in Shaheed
Beheshti University
• Scientific Executive Committee of Immunology Seminar held in Sari 2004
• Member of Scientific Committee of 11th annual congress of pathology and 5th
annual congress of Iranian cancer association
• Member of Scientific Committee of the 3rd
and 4th Annual Iranian Congress
on HIV/AIDS.
• Member of Scientific Committee of National Congress on Brucellosis(2011)
• Member of Scientific Committee of 1st international and 5th National
HIV/AIDS Congress (2012)
3
Journal referee for:
• International journal of infectious disease
• Iranian journal of infectious disease and tropical medicine
• Iranian journal of Clinical infectious diseases
• Iranian journal of pathology
• International journal of clinical practice
• Hepatitis monthly journal
• Iranian journal of clinical infectious diseases
• International Journal of STD & AIDS
• Indian Journal of Medical Sciences
• Journal of Clinical Virology
• Annals of Clinical Microbiology and Antimicrobials
• African Journal of Microbiology Research
Projects:
• Comparing efficacy of two strategies of HBV vaccination in HIV infected
patients (2012-2015)
• Frequency of human papillomavirus infection in colon tissues of patients with
colon adenocarcinoma and adenomatous polyps referring to Shaheed Beheshti
University hospitals (2012)
• Frequency of occult Hepatitis B infection and S gene mutations in dialysis
patients (2012)
• Seroepidemiology of IgG antibodies against Diphtheria and Tetanus in blood
donors of Arak city(2012)
4
• Comparing efficacy of two strategies of HBV vaccination in HIV infected
patients (2011)
• Serum profile of T helper 1 and 2 cytokines in patients with chronic hepatitis
C virus infection(2011)
• Association of interleukin-10 gene promoter polymorphisms with outcome of
hepatitis B virus infection (2011)
• TH1/TH2 cytokine levels as an indicator for disease progression in human
immunodeficiency virus type 1 infected patients(2011)
• Prevalence and genotype determination of HTLV 1 & 2 in HIV positive
patients (2010-2011)
• Frequency and genotype of hepatitis D virus in high risk groups for hepatitis B
virus acquisition (2010)
• Seroepidemiology of IgG antibody against Bordetella pertussis in 6-20 years
age group habitant of Tehran (2009-2010)
• Occult hepatitis B virus infection and mutations in the S gene region in
vaccinated children (2009-2010)
• Association of polymorphism of HLA-DRB1*13 and HLA-A*33 alleles with
outcome of hepatitis B virus infection (2008-2010)
• Frequency of human papillomavirus infection in patients with breast
carcinoma and benign breast samples referring to Shohada , Loghman and
Imam Khomeini hospitals (2009-2010)
• Seroepidemiology of IgG antibody against Bordetella pertussis in 6-20 years
age group habitant of Tehran (2009-2010)
• Seroepidemiology of antibody against Hepatitis A virus (anti-HAV) in 8
months to 20 years age group habitant of Tehran (2009)
5
• Frequency of occult Hepatitis B virus infection in blood donors with isolated
anti-HBc in Arak city (2009)
• Assessment of antibody levels to Hepatitis B virus surface antigen in routinely
vaccinated children via vaccination program of Iran (2009)
• Frequency of human papillomavirus infection in prostate tissues of patients
with prostate carcinoma and benign prostatic hyperplasia referring to Shaheed
Beheshti University hospitals (2008-2010)
• Prevalence and genotype of hepatitis G virus in Human Immunodeficiency
Virus (HIV) infected patients(2007-2008)
• Hepatitis B virus genotyping in hepatocellular carcinoma in Iranian patients
(2006-2008)
• Frequency of HLA Ι,ΙΙ(A,B,DRB) in chronic Hepatitis B virus patients(2006-
2007)
• Predictive value and cut off point of PPD in pulmonary tuberculosis patients in
Arak(2007-2009)
• Trial due to recombinant hepatitis B (HB) vaccine in hemodialysis patients of
3 dialysis center of Imam Khomeini, Sina , Amiralam Hospitals (2005-2007)
• Frequency of of Hepatitis G (HGV) in Blood Donors in Tabriz (2005-2006)
• Frequency of of Hepatitis G (HGV) in Hemodialysis and peritoneal dialysis
patients and dialysis ward staff in Imam Khomeini (2005-2006)
• Survey relation age of vaccinated infant (0, 2,6 months) and blood
concentration of mercury (2005-2006)
• Frequency of YMDD mutation in chronic Hepatitis B patients (2005-2006)
• Frequency of proteinuria in HIV positive patient in behavior diseases
consultant of Shaheed Beheshti Medical Sciences (2004-2005)
6
• Study relation of Antiretroviral drugs (include protease inhibitor) with
Lipodistrophy in HIV positive patients in behavior diseases consultant of
Shaheed Beheshti Medical Sciences (2004 -2005)
• Identification and detection of drug resistancy and genotyping of clinical
strains of enterococci isolated from admitted patients in Tehran University
Hospitals (2002 -2005)
Papers:
• Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi SH,
Aghakhani A, Mashayekhi P. Seroprevalence of Hepatitis E Virus infection
among Volunteer Blood Donors in Central Province of Iran in 2012. Iranian
Journal of Microbiology (in press)
• Ramezani A, Banifazl M, Eslamifar A , Ahmadi F, Razeghi E and Aghakhani
A. Outcome of Hemodialysis Patients with Occult Hepatitis B Virus Infection
At 4 Year Follow-up. Journal of Gastrointestinal and Liver Diseases (in press)
• Sofian M, Sheikholeslami M, Mahdaviani F, Aghakhani A, Banifaz M,
Eslamifar A, Sarmadian H, Deiri G, Ramezani A. Low Prevalence of Brucella
agglutinins in Blood Donors in Central Province of Iran. Iranian Journal of
Microbiology 5(1):24-27(2013)
• Ramezani A, Banifazl M, Aghakhani A. GB Virus C Overview: Insights into
Clinical Implication. Journal of Gastroenterology and Hepatology Research.
2(1): 343-349 (2013)
• Eslamifar A, Aghakhani A, Mohraz M, Banifazl M, Foroughi M, Ansari F,
Bolandghamat Z, Ramezani A. Seroepidemiology of Hepatitis E Virus
7
Infection in HIV Infected Patients. Iranian Journal of Infectious Diseases and
Tropical Medicine 17(59):33-36(2013)
• Sofian M, Aghakhani A, FaraziA, Banifazl M, Eslamifar A, Rashidi N,
Khadem-Sadegh A and Ramezani A. Serum Profile of T helper 1 and T
helper 2 Cytokines in Hepatitis C virus Infected Patients. Hepatitis Monthly
12(12):e6156 (2012)
• Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi A, McFarland W,
Eslamifar A and Ramezani A. Viral hepatitis and HIV infection among
injection drug users in a central Iranian city. Journal of Addiction Medicine
6(4):292-6 (2012)
• Aghakhani A, Banifazl M, Eslamifar A, Ahmadi F and Ramezani A. Viral
Hepatitis and HIV Infection in Hemodialysis Patients. Hepatitis Monthly
12(7): 463-464(2012)
• Ramezani A, Banifazl M, Eslamifar A, Sofian M and Aghakhani A. Occult
hepatitis B infection in different high risk patients. Hepatitis Monthly 12(7):
467-468(2012)
• Aghakhani A, Banifazl M, Velayati AA, Eslamifar A and Ramezani A.
Occult Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for
Consideration. Therapeutic Apheresis and Dialysis 16(4):328-33(2012)
• Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A and Aghakhani
A. The Influence of Human Leukocyte Antigen and IL-10 Gene
Polymorphisms in Hepatitis B Virus Outcome. Hepatitis Monthly 12(5):320-
325(2012)
8
• Eslamifar A, Ramezani A, Banifazl M, Khadem-Sadegh A and Aghakhani A.
Seroprevalence of IgG Antibodies against Bordetella Pertussis in Different
Age Groups in Tehran. Iranian Journal of Pathology 7(3):171-176(2012)
• Soufian S , Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Boland-
Ghamat Z, Khadem-Sadegh A and Ramezani A. No evidence of the Th1 to
Th2 cytokine shift during the course of HIV infection. Iranian Journal of
Pathology 7(2):88-93(2012)
• Ramezani A, Aghakhani A, Banifazl M, …….., Khadem-Sadegh A and
Mohraz M. Frequency of Human T-Cell Lymphotropic Virus (HTLV) Type 1
and 2 Infection in HIV Infected Patients. Iranian Journal of Pathology 7(1):9-
13(2012)
• Eslamifar A,
Ramezani A, Banifazl M and Aghakhani A. Tetanus and
diphtheria seroprevalence in patients infected with human immunodeficiency
virus. Iranian Journal of Pathology 7(1):27-31(2012)
• Soufian S, Mohraz M, Aghakhani A, Banifazl M, Froughi M, Eslamifar A,
Boland-Ghamat Z, Khadem-Sadegh A and Ramezani A. TH1/TH2 Cytokine
Levels in Human Immunodeficiency Virus Type 1 Infected Patient. Iranian
Journal of Infectious Diseases and Tropical Medicine 16(55):19-22(2012)
• Aghakhani A, Banifazl M, Izadi N, McFarland W, Sofian M, Khadem-Sadegh
A,….Eslamifar A, Ramezani A. Persistence of antibody to hepatitis B surface
antigen among vaccinated children in a low HBV endemic area. World Journal
of Pediatrics 7(4):358-60 (2011)
• Aghakhani A, Hamkar R, Parvin M, …., Banifazl M, Eslamifar A, Izadi N,
Jam S and Ramezani A. The Role of Human Papillomavirus Infection in
9
Prostate Carcinoma. Scandinavian Journal of Infectious Diseases 43(1): 64-
69(2011)
• Ramezani A, Banifazl M, Mohraz M, Eslamifar A, Rasoolinejad M and
Aghakhani A. Occult Hepatitis B Virus Infection: A Major Concern in HIV-
Infected Patients. Hepatitis Monthly 11(1):7-10 (2011)
• Ramezani A, Banifazl M, Eslamifar A and Aghakhani A. Association
between Human Papillomavirus Infection and Risk of Prostate Cancer
(Review article). Iranian Journal of Pathology 6 (1): 3-7(2011)
• Ramezani A, Banifazl M and Aghakhani A. Occult Hepatitis B Infection in
Chronic Hemodialysis Patients: Comparison of Results and Concepts.
Hepatitis Monthly 11(2):128-129 (2011)
• Kalantar E, Ramezani A, Hosseini S, Aghakhani A, Zarin Far N, Banifazl M
,………Eslamifar A and Sofian M. Interleukin-10 gene promoter
polymorphisms and hepatitis B virus infection outcome. Iranian Journal of
Infectious Diseases and Tropical Medicine 16(54):7-12(2011)
• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M……
Eslamifar A and Ramezani A. Frequency of hepatitis D virus infection in HIV
positive and hemodialysis patients. Iranian Journal of Infectious Diseases and
Tropical Medicine 16(54):41-46(2011)
• Hamkar R, Mohraz M, Lorestani S, Aghakhani A, Truong HM, McFarland W,
Banifazl M, Eslamifar A, ……. and Ramezani A. Assessing Subtype and
Drug-Resistance Associated Mutations among Antiretroviral-Treated HIV
Infected Patients. AIDS 24 (suppl 2):S85–S91 (2010)
• Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Khadem-Sadegh A and
Ramezani A. Occult Hepatitis B Virus Infection in Hemodialysis Patients
10
with Isolated Hepatitis B Core Antibody: A Multicentre Study. Therapeutic
Apheresis and Dialysis 14(3):349–353 (2010)
• Ramezani A, Banifazl M, EslamifarA and Aghakhani A. Serological pattern
of anti-HBc alone infers occult hepatitis B virus infection in high-risk
individuals in Iran. Journal of Infection in Developing Countries 4(10):658-
661 (2010)
• Ramezani A, Hamkar R, Aghakhani A, Lorestani SH, Banifazl M, Truong
HH, McFarland W, Foroughi M, Eslamifar A and Mohraz M. Subtype
Mutations and Related Drug-Resistance in Anti-Retroviral Treated HIV
Infected Patients. Iranian Journal of Infectious Diseases and Tropical
Medicine15(50):1-7(2010)
• Mohraz M, Ramezani A, Rasoulinejad M, Izadi M, Haji-abdolbaghi M,
Banifazl M and Aghakhani A. Comparison of the Efficacy and Safety of
Tenofovir-Emtricitabine Compound to other Antiretroviral Combinations.
Iranian Journal of Infectious Diseases and Tropical Medicine15(49):7-
10(2010)
• Eslamifar A, Aghakhani A, Banifazl M, Gachkar L, Khadem-Sadegh A,
Ramezani A. Seroprevalence of Bordetella Pertussis Antibodies in Different
Age Groups. Iranian Journal of Infectious Diseases and Tropical Medicine
15(49):43-47(2010)
• Sofian M, Aghakhani A, Farazi AA, Banifazl M, …, Eslamifar A, Khadem-
Sadegh A, Izadi N and Ramezani A. Seroepidemiology of Hepatitis A Virus
in Children of Different Age Groups in Tehran, Iran: Implications for Health
Policy. Travel Medicine and Infectious Disease 8(3): 176-179 (2010)
11
• Hamkar R, Parvin M, Ghavami N, Ramezani A, …, Banifazl M, ….,
Eslamifar A and Aghakhani A. Involvement of Human Papillomavirus
Infection in Prostate Carcinoma. Iranian Journal of Infectious Diseases and
Tropical Medicine 15(48):13-17(2010)
• Sofian M. Moeeni L, ……. Aghakhani A Banifazl M, Ramezani A. Predictive
value and cut of point of PPD in probable patients with pulmonary
tuberculosis. Iranian Journal of Infectious Diseases and Tropical Medicine
15(48):19-21(2010)
• Ramezani A, Azadmanesh K, Aghakhani A, Banifazl M, …. and Sofian M.
Frequency of occult hepatitis B virus infection in injection drug users. Iranian
Journal of Infectious Diseases and Tropical Medicine 15(48):39-42(2010)
• Sofian M, Aghakhani A, Banifazl M, …Eslamifar A,…Ramezani A. Lack of
occult hepatitis B virus infection among blood donors with isolated anti-HBc
living in a HBV low prevalence region in Iran. International Journal of
Infectious Diseases 14(4):e308–e310 (2010)
• Hamkar R, Aghakhani A, Soufian S, Banifazl M, ….., Eslamifar A and
Ramezani A. Surface Gene Mutations of Hepatitis B Virus among High Risk
Patients with Occult HBV Infection. Diagnostic Microbiology and Infectious
Disease 66(3):285-291(2010)
• Izadi N, Aghakhani A, Banifazl M , … Eslamifar A , .., Khadem-Sadegh A
and Ramezani A. Persistence of Anti-HBs antibody in HB Vaccinated
Children in a Low Endemic Area for HBV. Iranian Journal of Infectious
Diseases and Tropical Medicine 14(47):39-42(2010)
• Ramezani A, Hamkar R, Soufian S, Banifazl M ,……, Eslamifar A and
Aghakhani A. Genetic variability of the S gene of hepatitis B virus among
12
High Risk Patients with Occult HBV Infection. Iranian Journal of Infectious
Diseases and Tropical Medicine 14(47):13-18(2010)
• Ramezani A, Sofian M, Banifazl M, …., Eslamifar A, Gachkar L, Khadem-
Sadegh A and Aghakhani A. Seroepidemiology of Hepatitis A Virus in
Children Residing in Tehran. Iranian Journal of Infectious Diseases and
Tropical Medicine 14(46):23-26 (2009)
• Velayati AA, Aghakhani A,....Eslamifar A....Ramezani A. Association of
polymorphism of HLA-DRB1*13 and HLA-A*33 alleles with outcome of
hepatitis B virus infection. Iranian Journal of Infectious Diseases and Tropical
Medicine 14(46): 11-14 (2009)
• Syed alinaghi A, Jam S,….Ramezani A, Mohraz M. The effect of
mindfulness-based stress reduction program (MBSR) upon CD4 count status
of HIV/AIDS infected patients. Iranian Journal of Infectious Diseases and
Tropical Medicine 14(45):61-64(2009)
• Ramezani A, Banifazl M, Eslamifar A, Gachkar L, Aghakhani A. Prevalence
of hepatitis G virus in the sera of HIV infected patients with parenteral and
sexual exposure. Iranian Journal of Infectious Diseases and Tropical Medicine
14(45):27-29(2009)
• Ramezani A, Aghakhani A,…….. Eslamifar A, Sofian M. Occult hepatitis B
virus infection among blood donors in Arak. Iranian Journal of Infectious
Diseases and Tropical Medicine 14(45):37-40(2009)
• Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M. Frequency
of isolated anti-HBc in HIV- HCV co-infected patients. Iranian Journal of
Infectious Diseases and Tropical Medicine 14(45):17-22(2009)
13
• Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, ….Ramezani
A. Hepatitis B Virus Genotype in Iranian Patients with Hepatocellular
Carcinoma . International Journal of Infectious Diseases13 (6):685-89(2009).
• Ramezani A, Banifazl M,……Eslamifar A…..and Aghakhani A. Occult
hepatitis B virus infection in hemodialysis patients. Iranian Journal of
Infectious Diseases and Tropical Medicine14(44):27-30(2009)
• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, ….
Frequency of Isolated Hepatitis B Core Antibody in HIV-HCV Coinfected
Individuals. International Journal of STD & AIDS 20(5):336-338(2009)
• Ramezani A, Aghakhani A, Kalantar E, Eslamifar A, Banifazl M …. HLA-
A*3303 and *3301 Predispose Patients to Persistent Hepatitis B Infection.
Journal of Gastrointestinal and Liver Diseases 18(1):117-8(2009)
• Jam S, Ramezani A, Sabzvari D, Moradmand-Badie B, Seyedalinaghi S,
Jabbari H, …. A cross-sectional study of anemia in human immunodeficiency
virus-infected patients in Iran. Arch Iran Med. 2009 Mar; 12(2):145-50.
• Ramezani A, …, Banifazl M, Eslamifar A and Aghakhani A. Significance of
Hepatitis B Core Antibody as the Only Marker of Hepatitis B Virus Infection.
Iranian Journal of Pathology 4(2):80-84(2009)
• Ramezani A, Aghakhani A, Kalantar E, Banifazl M, Eslamifar A ,Velayati
AA. Association between Hepatitis B Virus Infection Outcome and HLA-A
and DRB1 Genotyping in North Part of Iran. Iranian Journal of Pathology
4(2):71-74(2009)
• Ramezani A,….,Aghakhani A,…..Prevalence of dyslipidemia and metabolic
abnormalities in HIV-infected patients. Acta Medica Iranica 47(2):83-
88(2009)
14
• Ramezani A,…..Aghakhani A, Taeb J,… Influence of HLA class Ι and II on
the outcome of hepatitis B virus infection Iranian Journal of Infectious
Diseases and Tropical Medicine13(43):1-4(2009)
• Ramezani A, ………Aghakhani A, Eslamifar A,…and Mohraz M. Frequency
of Occult Hepatitis B Virus Infection in HIV Infected Patients. Iranian Journal
of Infectious Diseases and Tropical Medicine13(43):17-20(2009)
• Kariminia A, sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati M
and Ramezani A. Comparison of QuantiFERON TB-G test to TST for
detecting latent tuberculosis infection in a high-incidence area containing
BCG-vaccinated population. Journal of Evaluation in Clinical
Practice.15(1):148–151(2009)
• Ramezani A, Eslamifar A, ……and Aghakhani A. Efficacy and Long-term
Immunogenicity of Hepatitis B Vaccine in Hemodialysis Patients.
International Journal of Clinical Practice 63(3): 394-97(2009)
• Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A,….Taeb J,
Aghakhani A… Association of Human Leukocyte Antigen polymorphism
with Outcomes to Hepatitis B Virus Infection. Journal of Gastroenterology
and Hepatology 23(11): 1716-1721 (2008).
• Aghakhani A, …, Banifazl M, …. Eslamifar A,…and Ramezani A.
Asymptomatic proteinuria in HIV-infected outpatients. Iranian Journal of
Infectious Diseases and Tropical Medicine 13(42):9-13(2008)
• Ramezani A, Eslamifar A,…… Aghakhani A ,…. High Blood Mercury
Levels in Iranian Infants: cause for concern. Iranian Journal of Pathology
3(4):186-190 (2008)
15
• Ramezani A, Mohraz M, Vahabpour R,….Eslamifar A,….Aghakhani
A,…Hekmat S. Frequency of Hepatitis G Virus Infection among HIV Positive
Subjects with Parenteral and Sexual Exposure. Journal of Gastrointestinal and
Liver Diseases 17(3):269-72 (2008)
• Azadmanesh K, …, Aghakhani A,……..Eslamifar A,….Ramezani A. Occult
Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B
Core Antibody. Intervirology 51(4):270-274 (2008)
• Eslamifar A, Razzaghi-Abyaneh M,…… Ramezani A, Deljoodokht Z and
Aghakhani A. Frequency and Identification of Fungal Strains in Chronic
Rhinosinusitis Patients. Iranian Journal of Pathology 3(3):135-139(2008)
• Ramezani A, Aghakhani A ,… Eslamifar A,….Anemia prevalence and
related factors in a cohort of HIV- infected patients .Iranian Journal of
Pathology 3(3):125-128(2008)
• Hamkar R, Zamani N, Ramezani A, Eslamifar A, ......and Aghakhani A.
Identification of Hepatitis B Virus Genotype in Iranian Hepatocellular
Carcinoma Patients. Iranian Journal of Infectious Diseases and Tropical
Medicine13(41):23-29(2008)
• Ramezani A,…… Aghakhani A, Eslamifar A,….. Prevalence and Genotype
of Hepatitis G virus infection in HIV Positive Patients. Iranian Journal of
Infectious Diseases and Tropical Medicine13(41):7-13(2008)
• Hekmat S, …, Jam S, Bahramali G, Banifazl M, Aghakhani A, Eslamifar A,
…, Ramezani A. Frequency and Genotype of GB Virus C among Iranian
Patients Infected with HIV. Journal of Medical Virology 80(11):1941-
1946(2008)
16
• Ramezani A, …, Banifazl M, Eslamifar A,….and Aghakhani A. Frequency
and Associated Factors of Proteinuria in Iranian HIV-Positive Patients.
International Journal of Infectious Diseases 12(5):490-94(2008)
• Ramezani A, Aghakhani A, Eslamifar A….Taeb J,….. Long-Term Immunity
of Hepatitis B Vaccine in Patients Undergoing Hemodialysis. Iranian Journal
of Infectious Diseases and Tropical Medicine.13(40):21-24(2008)
• Kariminia A, sharifnia Z, Aghakhani A, .. Eslamifar A,… and Ramezani A.
Evaluation of the blood gamma interferon assay for detection of latent
Tuberculosis infection: potential to replace the Mantoux skin test. Iranian
Journal of Infectious Diseases and Tropical Medicine13 (40):1-4(2008).
• Ramezani A, Velayati AA.,…….and Aghakhani A. Rate of YMDD Motif
Mutants in Lamivudine-Untreated Iranian Patients with Chronic Hepatitis B
Virus Infection. International Journal of Infectious Diseases. 12(3):252-
55(2008)
• Ramezani A, Eslamifar A,, ……and Aghakhani A. Persistence of Hepatitis B
Vaccine Immunity in Hemodialysis Patients.Therapeutic Apheresis and
Dialysis.12(2):143-146 (2008).
• Eslamifar A, Ramezani A, Razzaghi Abyaneh M, Fallahian V, Mashayekhi P,
…, Fayaz A and Aghakhani A. Animal Bites in Tehran, Iran. Archives of
Iranian Medicine 11(2):200-202(2008)
• Ramezani A, Mohraz M…….Dyslipidemia and metabolic abnormalities in
HIV-infected patients. Iranian Journal of Infectious Disease and Tropical
Medicine. 12(39):5-9(2008).
• Hamkar R, Yahyapour Y,…Ramezani A….Prevalence of viral agents among
children with acute gastroenteritis in Mazandaran province, 2004-2005.
17
Iranian Journal of Infectious Disease and Tropical Medicine. 12(39):5-
9(2008).
• Sofian M., Aghakhani A., Velayati A.A., Banifazl M, Eslamifar A. and
Ramezani A. Risk factors for human brucellosis in Iran: a case control study.
International Journal of Infectious Diseases .12(2):157-61(2008)
• Ramezani A. Gachkar L, Eslamifar A,….Detection of hepatitis G virus
envelope protein E2 antibody in blood donors. International Journal of
Infectious Diseases .12(1):57-61(2008)
• Ramezani A, …, Banifazl M, Eslamifar A,….and Aghakhani A. Metabolic
abnormalities in HIV-positive patients receiving highly active antiretroviral
therapy. Iranian Journal of Pathology 2 (4):154-58 (2007).
• Jam S, Sabzevari D, Aghakhani A, Eslamifar A, Banifazl M and Ramezani A.
Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas
aeruginosa in a pediatric hospital. Iranian Journal of Pathology 2(4):144-
48(2007)
• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G
Virus Exposure in Dialysis Patients. International Urology and Nephrology
.39(4): 1257-1263 (2007).
• Soofian M,…. Eslamifar A, Aghakhani A, Ramezani A. Eosinophilic
gastroenteritis: A case report. Iranian Journal of Infectious Disease and
Tropical Medicine .12(38):63-6(2007).
• Ramezani A, Eslamifar A, Aghakhani A,…..Blood mercury levels in infants
receiving vaccines containing Thimerosal. Iranian Journal of Infectious
Disease and Tropical Medicine. 12(38):17-20(2007).
18
• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G
virus (HGV) Exposure in Dialysis Staff. Therapeutic Apheresis and Dialysis.
11(5):370-374(2007).
• Ramezani A, Gachkar L, Eslamifar A…Prevalence of Hepatitis G virus
exposure in blood donors. Iranian Journal of Infectious Disease and Tropical
Medicine. 12(37) (2007) .
• Eslamifar A, Tirgari F, Hamkar R, Ramezani A …… Deljoodokht Z and
Aghakhani A. Role of the Human Papillomavirus infection in Esophageal
Squamous Cell Carcinoma. Iranian Journal of Pathology. 2(1):11-16(2007).
• Ramezani A, Aghakhani A……Eslamifar A…. Natural YMDD mutants in
chronic B hepatitis. Iranian Journal of Infectious Diseases and Tropical
Medicine. 12(37): 1-6(2007).
• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A,..... Frequency of
Human Papillomavirus Infection in Iranian Esophageal Squamous Cell
Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-
62(2007)
• Eslamifar A., Aghakhani A. Ramezani A.,... Detection of Hepatitis G Virus
Envelope Protein E2 Antibody in Dialysis Staff .Iranian Journal of Infectious
Diseases and Tropical Medicine. 11(35): 73-79 (2007).
• Ramezani A, Gachkar L, Eslamifar A…Prevalence of Hepatitis G virus
exposure in blood donors. Infectious diseases and tropical medicine journal.
37(12), (2007).
• Ramezani A, Mohraz M,…..Anemia and associated factors in individuals
with Human immunodeficiency virus infection. Infectious diseases and
tropical medicine journal. 36(12):29-32(2007).
19
• Ramezani A, Aghakhani A……Eslamifar A…. Natural YMDD mutants in
chronic B hepatitis. Infectious diseases and tropical medicine journal. 12(37):
1-6(2007).
• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A, et al..... Frequency of
Human Papillomavirus Infection in Iranian Esophageal Squamous Cell
Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-
62(2007)
• Eslamifar A., Aghakhani A. Ramezani A.,... Detection of Hepatitis G Virus
Envelope Protein E2 Antibody in Dialysis Staff .Iranian Journal of Infectious
Diseases and Tropical Medicine, 11( 35): 73-79 (2007)
• Ramezani A, Mohraz M, Gachkar L. (2006) Epidemiologic situation of
HIV/AIDS in Iranian patients referred to ... Archives of Iranian Medicine. 9(
4):315-318.
• Ramezani A, Mohraz M, Gachkar L. (2006) Frequency of positive purified
protein derivative in Human Immunodeficiency Virus infected individuals.
Archives of Iranian Medicine, 9 (3): 218-221.
• Ramezani A, Eslami far A, Amirkhani A, Hazrati M, Taeb J and Deljoo Z.
Factors influencing to hepatitis B vaccination response in hemodialysis
patients of Tehran (Iran) Iranian Journal of Infectious Diseases and Tropical
Medicine, Vol. 10, No. 32. (2006).
• Eslamifar A., Aghakhani A., Hamkar R., Ramezani A., Tirgari F., Frootan H.,
Mirmomen Sh., Gheini MH. , Deljoodookht Z., Taeb J. (2006) Detection of
High Risk Human Papillomaviruses in Esophageal Squamous Cell Carcinoma
by PCR and DNA Sequencing. Iranian Journal of Infectious Diseases and
Tropical Medicine, Vol. 11, No. 33.
20
• Roshan M.R, Mohraz M, Ramezani A, Haji Ahmadi M and Velayati A.A.
(2006) Efficacy of gentamycine plus doxycycline versus Streptomycin plus
doxycyline. Clinical Infectious Disease. 15; 42(8).
• Ramezani A, …, Asgharzadeh A, Parastan R, Aliahmadi A Eslamifar A,
Velayati A.A. (2005) Molecular epidemiology of clinical strains of enteococci
Faecium in Tehran hospitals. Iranian Journal of Infectious Diseases and
Tropical Medicine, Vol. 10, No. 31.
• Ramezani A, Eslamifar A, Nazgooei F. (2004) Epidemiological Study of
animal bites in persons referred to institute Pasteur of Iran (Tehran province)
2003. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 9,
No. 27.
• Ahmadi F, Maziyar S, Ramezani A, Lesan. (2004) Evaluation of hepatitis B
immunity and influencing factors on hemodialysis patients response to HB
vaccine. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 9,
No. 27
• Ramezani A, Eslamifar A, Hazrati M. (2004) Relation of vaccine includes
thiomersal with neurodevelopment disorders in neonates and embryonic
periods. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 9,
No. 26.
• Etemadi G, Ramezani A. (2004) Report of several cases of streptococcus
pneumonia in rural family (Qom). Iranian Journal of Infectious Diseases and
Tropical Medicine, Vol. 9, No. 25.
• Ramezani A, Eslami far A, Nazgooei F, Eslami L. (2004) Epidemiology of
animal rabies in Tehran province (2002-2003). Iranian Journal of Infectious
Diseases and Tropical Medicine, Vol. 9, No. 25.
21
• Ramezani A, Mohraz M, Nazgooei F. (2004) Study frequency of M. Hominis
and ureaplasma urealyticum in patients referred to private office. Iranian
Journal of Infectious Diseases and Tropical Medicine, Vol. 9, No. 24.
• Vahdani P, Darreh F, …, Ramezani A. (2004) First case of infantile botulism
in Iran. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 9,
No. 24.
• Roshan M.R, Ramezani A. (2002) Result of long term follow up in chronic
carrier of Hepatitis B in Babol (2000-2001). Iranian Journal of Infectious
Diseases and Tropical Medicine, Vol. 16, No. 7.
• Ramezani A. Effectiveness of Ethanol concentration on resistant M.
Tuberculosis in vitro. (2002) Iranian Journal of Infectious Diseases and
Tropical Medicine, Vol. 8, No. 20.
• Ramezani A , Mohraz M, Asadi S, Nazgooei F, Eslami far A. (2002) Survey
situation of nosocomial infection due to enterococci in Tehran Hospitals.
Infectious Diseases and Tropical Medicine Journal, Vol. 7, No. 19.
• Ramezani A, Mohraz M, Asadi S ,Nazgooei F, Eslamifar A. (2002) Survey
situation of nosocomial infection due to enterococci in Tehran hospitals.
Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 7, No. 19.
• Babaei A, Ramezani A. (2002) Study of garlic effectiveness on resistant M.
Tb. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 7, No.
19.
• Feizabadi MM, Ali Ahmadi A, Parastan R, Ramezani A, Asadi S. (2002)
Biotype variation in E. Facium strains isolated from admitted patients in
Tehran Hospitals. Iranian Journal of Infectious Diseases and Tropical
Medicine, Vol. 7, No. 18.
22
• Feizabadi MM, Aliahmadi A, Mobasheri F, … , Ramezani A. (2002)
Identification antimicrobial resistancy pattern of Enterococci strains isolated
from patients admitted to Tehran University Hospitals. Infectious Diseases and
Tropical Medicine Journal, Vol. 7, No. 16.
Books:
• New edition of "Guide to antimicrobial therapy and vaccination" .Chief
Editor: Iranian Society for Infectious Diseases and Tropical Medicine
publication (2013)
• New edition of "Guide to antimicrobial therapy and vaccination". Pousheh
Publication, Tehran, Iran (2012)
• New edition of "Guide to antimicrobial therapy and vaccination" .Chief
Editor: Iranian society for infectious diseases and tropical medicine
publication (2010).
• Tourism Medical Information and Guideline. Pejvak Ghalam and BUMS
publication. Tehran (2010)
• Risk factors for human brucellosis in Iran (In English & German). VDM
Verlag publication (2009).
• New edition of "Guide to antimicrobial therapy and vaccination" .Chief
Editor: Iranian society for infectious diseases and tropical medicine
publication (2009).
• International Travel Medicine. Iran Helal Institute of Applied Science and
Technology Publication, Tehran (2009).
• New edition of "Guide to antimicrobial therapy" .Chief Editor: Iranian Society
for Infectious Diseases and Tropical Medicine (2008).
23
• New edition of "Guide to antimicrobial therapy" .Chief Editor: Iranian Society
for Infectious Diseases and Tropical Medicine (2007).
• New edition of "Guide to antimicrobial therapy" .Chief Editor: Iranian Society
for Infectious Diseases and Tropical Medicine (2006).
• Guide to Antimicrobial Therapy. Chief Editor: Iranian Society for Infectious
Diseases and Tropical Medicine (2005).
• Abstract Book of National Iranian Congress of Brucellosis Chief Editor
Shaheed Beheshti University. ISBN 964-7271-83-2, 2005
• Antibiotic Guidelines. Chief Editor: Iranian Society for Infectious Diseases
and Tropical Medicine (2004).
• Nelson Textbook of Pediatrics, Chapter of Neonatology Translation English to
Persian, Teimoorzadeh Publication ISBN 964-456-914-8, 2004
• Nelson Textbook of Pediatrics, Chapter of Immunology, Allergy, and
Rheumatology Translation English to Persian, Teimoorzadeh Publication
ISBN 964-456-915-6 ,2004
• Nelson Textbook of Pediatrics, Chapter of Infectious Diseases Translation
English to Persian, Teimoorzadeh Publication ISBN 964-456-898-2 ,2004
• Textbook of Infectious Diseases. Chief Editor: Poursina Publication ISBN
964-5670-64-0, 2002
• Textbook of Tuberculosis. Chief : Poursina Publication ISBN 964-5670-66-7,
2002
• Nelson Textbook of Pediatrics, Chapter of Infectious Diseases Translation
English to Persian, Teimoorzadeh Publication 2000
• Nelson Textbook of Pediatrics, Chapter of Neonatology Translation English to
Persian, Teimoorzadeh Publication 2000
24
• Nelson Textbook of Pediatrics, Chapter of Respiratory Diseases Translation
English to Persian, Teimoorzadeh Publication 2000
• Nelson Textbook of Pediatrics, Chapter of Immunology Translation English to
Persian, Teimoorzadeh Publication, ISBN 964-456-457-X, 2000
• Nelson Textbook of Pediatrics, Chapter of Allergy Translation English to
Persian, Teimoorzadeh Publication, ISBN 964-456-457-X ,2000
• Epidemiology and Health. Editor: Arzandeh Publication, ISBN 964-92092-5-
5, 2000
Presentations
1. Sofian M, Aghakhani A, Amir-Moezzi R , Zarinfar N, Banifazl M, Eslamifar A
and Ramezani A. Prevalence of HIV, HCV and HBV Infections and Associated
Risk Factors among Injecting Drug Users in Arak City. 21st Iranian congress on
infectious diseases and tropical medicine, Tehran, Iran (2013)
2. Sofian M, Sheikholeslami M, Sarmadian H, Mahdaviani F, Aghakhani A,
Eslamifar A, Deiri GH, Ramezani A. Seroprevalence of Brucellosis Antibodies
in Blood Donors in Central Province of Iran. 21st Iranian congress on infectious
diseases and tropical medicine, Tehran, Iran (2013)
3. Sofian M, Safaeipour L, Aghakhani A, Banifazl M, Eslamifar A, Farazi A, Didgar
F, Ramezani A. Importance of Family Members Screening of Cases with Acute
Brucellosis. 21st Iranian congress on infectious diseases and tropical medicine,
Tehran, Iran (2013)
4. Ramezani A, Mohraz M, Eslamifar A, Banifazl M, ….. and Aghakhani A.
Hepatitis E virus co-infection in HIV infected patients. 21st Iranian congress on
infectious diseases and tropical medicine, Tehran, Iran (2013)
25
5. Aghakhani A, Aghasadeghi MR, Banifazl M, Eslamifar A, …..and Ramezani A.
Occult Hepatitis B Virus Infection in Hemodialysis Patients. 21st Iranian congress
on infectious diseases and tropical medicine, Tehran, Iran (2013)
6. Ramezani A, Eslamifar A, Banifazl M, Ahmadi F, Aghakhani A. Follow up of
Hemodialysis Patients with Occult Hepatitis B Virus Infection. 21st Iranian
congress on infectious diseases and tropical medicine, Tehran, Iran (2013)
7. Ramezani A, Aghasadeghi M, Bahramali G, Aghakhani A, Banifazl M, …….
Eslamifar A, Siadat S, Mohraz M. Frequency of hepatitis D virus infection in
HIV-positive and haemodialysis patients in Iran. 22nd
European Congress of
Clinical Microbiology and Infectious Diseases (ECCMID), London, UK (2012)
8. Soufian S, Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M.
Reduction in interleukin-2 serum levels but lack of evidence of the Th1 to Th2
cytokine shift during the course of HIV infection. 22nd
European Congress of
Clinical Microbiology and Infectious Diseases (ECCMID), London, UK (2012)
9. Sofian M, Banifazl M, Aghakhani A, ….. Ramezani A. Evaluation of interleukin-
10 gene promoter polymorphisms and hepatitis B virus infection outcome. 22nd
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID),
London, UK (2012)
10. Ramezani A, Sofian M, Aghakhani A, Farazi A, Banifazl M,. Eslamifar A,
Velayati A. Serum profile of T helper 1 and T helper 2 cytokines in HCV-infected
patients. 22nd
European Congress of Clinical Microbiology and Infectious
Diseases (ECCMID), London, UK (2012)
11. Sofian M , Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, …..
Comparison of Brucella Induced epididymo-orchitis with Nonspecific Epididymo-
26
orchitis in an Endemic Area for Brucellosis. 20th
Iranian congress on infectious
diseases and tropical medicine, Tehran, Iran (2011)
12. Ramezani A, Sofian M, Aghakhani A ,…. Banifazl M, Eslamifar A, ….. Serum
Profile of T helper 1 and T helper 2 Cytokines in HCV Infected Patients. 20th
Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2011)
13. Ramezani A, Aghasadeghi MR, Bahramali G, Aghakhani A, Banifazl M,
…..Eslamifar A, ….. Frequency of hepatitis D virus infection in HIV positive and
hemodialysis patients in Iran. 20th
Iranian congress on infectious diseases and
tropical medicine, Tehran, Iran (2011)
14. Ramezani A, Aghakhani A, Banifazl M, Forough M, Eslamifar A and Mohraz M.
Seroprevalence of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2
Infection in HIV Infected Patients. 20th
Iranian congress on infectious diseases
and tropical medicine, Tehran, Iran (2011)
15. Ramezani A, Sofian M, Banifazl M, Aghakhani A,….. Eslamifar A, …..
Evaluation of Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B
Virus Infection Outcome. 20th
Iranian congress on infectious diseases and tropical
medicine, Tehran, Iran (2011)
16. Eslamifar A, Ramezani A, Mohraz M, Banifazl M, Forough M and Aghakhani A.
Tetanus and diphtheria seroprevalence in HIV infected patients. 20th
Iranian
congress on infectious diseases and tropical medicine, Tehran, Iran (2011)
17. Panel about Brucellosis. 10th
midyear conference of infectious diseases. Babolsar,
Iran (2011)
18. Ramezani A, ….., Aghakhani A, Soufian S, Eslamifar A and Banifazl M.
Mutations in the S gene region of hepatitis B virus in High Risk Patients with
Occult HBV Infection. 20th ECCMID, Vienna, Austria (2010)
27
19. Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A and Ramezani A.
Distribution of pertussis antibodies among Iranian children of different age
groups. 20th ECCMID, Vienna, Austria (2010)
20. Ramezani A, Hamkar R, Aghakhani A, Banifazl M, ….. Prevalence of Secondary
Resistant Mutations to Antiretroviral Drugs in Iranian HIV Infected Patients. 20th
ECCMID, Vienna, Austria (2010)
21. Ramezani A, Aghakhani A, Sofian M, …., Khadem-Sadegh A and Banifazl M.
Seroepidemiology of Hepatitis A Virus in Iranian Children. 20th ECCMID,
Vienna, Austria (2010)
22. Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of isolated
antibody to hepatitis B core antigen in HIV- HCV coinfected individuals. 14th
ICID - Miami, Florida, USA (2010)
23. Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Association of
polymorphism of HLA-DRB1 13 and HLA-A 33 alleles with outcome of hepatitis
B virus infection. 14th ICID - Miami, Florida, USA (2010)
24. Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M and Ramezani A.
The Role of Human Papillomavirus Infection in Prostate Carcinoma. 14th ICID -
Miami, Florida, USA (2010)
25. Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. No evidence of
occult hepatitis B virus infection among anti-HBc-positive blood donors in an area
of low endemicity for HBV. 14th ICID - Miami, Florida, USA (2010)
26. Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of occult
hepatitis B virus infection in HIV infected patients. 14th ICID - Miami, Florida,
USA (2010)
28
27. Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. The epidemiology
of tuberculosis in Arak city, Central province of Iran from 1997-2007. 14th ICID -
Miami, Florida, USA (2010)
28. Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Anti-HBs titers in
vaccinated children and adolescents: Implication for booster administration. 14th
ICID - Miami, Florida, USA (2010)
29. Ramezani A, Banifazl M,…….. Eslamifar A,… Aghakhani A. Prevalence of
Occult Hepatitis B Infection in Iranian Injection Drug Users. 14th ICID - Miami,
Florida, USA (2010)
30. Sofian M,….. Aghakhani A, Banifazl M, Ramezani A. Predictive value and cut
off point of PPD in probable patients with pulmonary tuberculosis. 14th ICID -
Miami, Florida, USA (2010)
31. Sofian M,….. Ramezani A,…. Aghakhani A, Banifazl M. Prevalence of isolated
hepatitis B core antibody among injection drug users in central province of Iran.
14th ICID - Miami, Florida, USA (2010)
32. Eslamifar A, Ramezani A, Banifazl M, Bidari F, Moradi A and Aghakhani A.
Association of Human Papillomavirus and Breast Carcinoma.19th Iranian
congress on infectious diseases and tropical medicine, Tehran, Iran (2010)
33. Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Banifazl M. Occult and
chronic hepatitis B, hepatitis C, and HIV infections and co-infections among
injection drug users. 19th Iranian congress on infectious diseases and tropical
medicine, Tehran, Iran (2010)
34. Panel about Hepatitis. 9th
midyear conference of infectious diseases. Kish, Iran
(2010)
29
35. Ramezani A, Mohraz M, Aghakhani A, ….. Eslamifar A, …. Genotype
characterization of hepatitis G virus isolates from Iranian patients infected with
human immunodeficiency virus. 19th ECCMID, Helsinki, Finland(2009)
36. Ramezani A, Aghakhani A, Mohraz M, Eslamifar A, Khadem-Sadegh A,
Banifazl M. Occult hepatitis B virus infection in “anti-HBc alone” haemodialysis
patients. 19th ECCMID, Helsinki, Finland(2009)
37. Sofian M, Ramezani A, ….. Aghakhani A, Eshrati B, Eslamifar A, Banifazl M.
Predictive value of purified protein derivative in pulmonary tuberculosis in a high
BCG-vaccinated population. 19th ECCMID, Helsinki, Finland(2009)
38. Aghakhani A, Hamkar R, …Eslamifar A,….Ramezani A. Identification of
hepatitis B virus genotype in patients with hepatocellular carcinoma in Iran.19th
ECCMID, Helsinki, Finland (2009)
39. Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.Significance
of Hepatitis B Core Antibody as the Only Marker of Hepatitis B Virus Infection.
The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran (2009)
40. Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Khadem-Sadegh A and
Ramezani A. Frequency of isolated antibody to hepatitis B core antigen in HIV-
HCV coinfected individuals. The 3rd Annual Iranian Congress on HIV/AIDS.
Tehran, Iran (2009)
41. Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A,……Hamkar R.
Frequency of Occult Hepatitis B Virus Infection and its Surface Mutants in HIV
Positive Patients. The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran
(2009)
30
42. Hamkar R, Ramezani A, Aghakhani A, Banifazl M, …Mohraz M. Frequency of
drug resistance mutations in HIV-positive patients receiving antiretroviral therapy.
The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran (2009).
43. Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Izadi N, Banifazl M. Occult
hepatitis B virus infection in blood donors with isolated anti-HBc. 18th
Iranian
congress on infectious diseases and tropical medicine, Tehran, Iran (2009).
44. Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M, Ramezani A.
Association of Human Papillomavirus with Prostate Cancer. 18th
Iranian congress
on infectious diseases and tropical medicine, Tehran, Iran (2009).
45. Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A, Ramezani A.
Seroepidemiology of pertussis antibodies among children of different age groups.
18th
Iranian congress on infectious diseases and tropical medicine, Tehran, Iran
(2009).
46. Ramezani A, …., Aghakhani A, Eslamifar A, Soufian S, Banifazl M. Hepatitis B
virus Surface Gene Mutations in High Risk Patients with Occult HBV Infection.
18th
Iranian congress on infectious diseases and tropical medicine, Tehran, Iran
(2009).
47. Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl M.
Age specific seroprevalence of hepatitis A antibody: Implications for health
policy. 18th
Iranian congress on infectious diseases and tropical medicine, Tehran,
Iran (2009).
48. Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl M.
Seroprevalence of hepatitis B surface antibody in children subjected to the
Expanded Programme on Immunization (EPI). 18th
Iranian congress on infectious
diseases and tropical medicine, Tehran, Iran (2009).
31
49. Panel about chronic hepatitis B. 8th
midyear conference of infectious diseases.
Babolsar, Iran (2009).
50. Ramezani A, …, Eslamifar A, …, Aghakhani A, Edalat R, Hekmat S. Hepatitis G
virus infection in patients infected with the human immunodeficiency virus. 13th
ICID - Kuala Lumpur, Malaysia (2008)
51. Ramezani A,…… Eslamifar A,…..Taeb J, Aghakhani A….. Association between
HLA-A, B, DRB1 alleles and susceptibility or resistance to chronic hepatitis B.
13th ICID - Kuala Lumpur, Malaysia (2008)
52. Ramezani A,…. Aghakhani A, Eslamifar A…. Prevalence of Metabolic
abnormalities in HIV-Infected Patients Receiving Highly Active Antiretroviral
Therapy and antiretroviral-naive patients. 13th ICID - Kuala Lumpur, Malaysia
(2008)
53. Ramezani A, Eslamifar A, ….. and Aghakhani A. Long term Immune response to
hepatitis B vaccine in hemodialysis patients. 13th ICID - Kuala Lumpur, Malaysia
(2008)
54. Ramezani A, … Eslamifar A,……and Aghakhani A. Comparison of IFN-gamma
assay and Tuberculin Skin Test for detecting latent tuberculosis infection in BCG-
vaccinated population. 13th ICID - Kuala Lumpur, Malaysia (2008)
55. Eslamifar A, Aghakhani A, Ramezani A,……. The role of fungi in the etiology
of chronic rhinosinusitis. 12th International Congress of Mycology. Istanbul,
Turkey(2008)
56. Soofian M, Ramezani A, ...., Aghakhani A, Eslamifar A. Risk factors for human
brucellosis in Iran: a case control study. ECCMID-ICC, Munich, Germany (2007).
57. Aghakhani A, Hamkar R,…….Eslamifar A,…..Ramezani A. Genotype
Characterization of Hepatitis B Virus Isolates from Iranian Patients with
32
Hepatocellular Carcinoma . 10th annual congress of pathology and 4th annual
congress of Iranian cancer association, Tehran, Iran (2008).
58. Eslamifar A,…. Ramezani A,….and Aghakhani A. Frequency of Fungi and
Eosinophilic Granulocytes in Chronic Rhinosinusitis . 10th annual congress of
pathology and 4th annual congress of Iranian cancer association, Tehran, Iran
(2008).
59. Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.
Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis B
Virus Infection. 17th Iranian congress on infectious diseases and tropical
medicine, Tehran, Iran (2008).
60. Ramezani A,….. Aghakhani A,… Eslamifar A and Velayati AA. Genotype
characterization of hepatitis G virus isolates from Iranian patients infected with
human immunodeficiency virus (HIV). 17th Iranian congress on infectious
diseases and tropical medicine, Tehran, Iran (2008).
61. Ramezani A, …, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A,
Velayati AA. Frequency of isolated antibody to hepatitis B core antigen in HIV-
HCV coinfected individuals. 17th Iranian congress on infectious diseases and
tropical medicine, Tehran, Iran (2008).
62. Ramezani A, Aghakhani A,…. Eslamifar A,… Association of polymorphism of
HLA-DRB1*13 and HLA-A *33 alleles with outcome of hepatitis B virus
infection. 17th Iranian congress on infectious diseases and tropical medicine,
Tehran, Iran (2008).
63. Ramezani A, Mohraz M, Aghakhani A, Banifazl M, …. Frequency of occult
hepatitis B virus infection in HIV infected patients. 17th Iranian congress on
infectious diseases and tropical medicine, Tehran, Iran (2008).
33
64. Ramezani A, Aghakhani A, Eslamifar A, Khadem-Sadegh A, Banifazl M. Occult
hepatitis B virus infection in "anti-HBc alone" hemodialysis patients. 17th Iranian
congress on infectious diseases and tropical medicine, Tehran, Iran (2008).
65. Panel about Treatment of HBeAg negative chronic Hepatitis B. 7th midyear
conference of infectious diseases. Isfahan, Iran (2008).
66. Ramezani A, Mohraz M, Banifazl M, Aghakhani A…. Frequency of proteinuria
among HIV-infected patients .ECCMID-ICC, Munich, Germany (2007).
67. Eslamifar A., Aghakhani A, Ramezani A,…… Prevalence of hepatitis G
exposure in patients on chronic dialysis. 21st European Congress of Pathology,
Istanbul, Turkey (2007).
68. Kariminia A, sharifnia Z, Aghakhani A, .. Eslamifar A,… and Ramezani A.
Performance of QuantiFERON TB-G Test for detecting latent tuberculosis
infection in BCG-vaccinated population. 16th Iranian congress on infectious
diseases and tropical medicine, Tehran, Iran (2007).
69. Ramezani A, Eslamifar. A ...and Aghakhani A. Persistence of Hepatitis B
Vaccine Immunity in Hemodialysis Patients.16th Iranian congress on infectious
diseases and tropical medicine, Tehran,Iran (2007).
70. Ramezani A,... Aghakhani A, Eslamifar A... Frequency of hepatitis B and
hepatitis C virus infections in HIV infected subjects.16th Iranian congress on
infectious diseases and tropical medicine, Tehran, Iran (2007).
71. Ramezani A, Mohraz M, Aghakhani A, Eslamifar A,... Impact of antiretroviral
treatment on lipid profile in HIV infected patients. 16th Iranian congress on
infectious diseases and tropical medicine, Tehran,Iran (2007).
34
72. Ramezani A, Mohraz M ... Aghakhani A, Eslamifar A... Anemia in HIV-infected
patients receiving highly active antiretroviral therapy. 16th Iranian congress on
infectious diseases and tropical medicine, Tehran,Iran (2007).
73. Ramezani A. Hasanjani Roshan MR... Eslamifar A, Taeb J, Aghakhani A...
Influence of HLA class І and II alleles on the outcome of hepatitis B virus
infection. 16th Iranian congress on infectious diseases and tropical medicine,
Tehran, Iran (2007).
74. Ramezani A ... Eslamifar A and Aghakhani A. Detection of YMDD mutation in
Iranian chronic hepatitis B patients before lamivudine treatment. 9th annual
congress of pathology and 3rd annual congress of Iranian cancer association,
Tehran, Iran (2007).
75. Mohraz M, Ramezani A, Banifazl M...and Aghakhani A. Frequency and
Associated Factors of Proteinuria in HIV-Positive Patients .The first annual AIDS
research congress of Iran. Tehran, Iran (2007).
76. Panel about Hepatitis in 6th midyear conference of infectious diseases. Babolsar
16-19 Oct (2007).
77. Esalamifar A, Aghakhani A, Hamkar R, Ramezani A....Frequency of Human
Papillomavirus Infection in Esophageal Squamous Cell Carcinoma of Iranian
patients. 12th International Congress on Infectious Diseases, Lisbon, Portugal
(2006)
78. Eslamifar A, Ramezani A....and Aghakhani A. Hepatitis G virus exposure in
dialysis patients. 8th annual congress of pathology and 2nd congress of oncology,
Tehran, Iran (2006)
35
79. Eslamifar A , Hamkar R, Ramezani A....and Aghakhani A. Role of human
papillomavirus infection in esophageal carcinoma.8th annual congress of
pathology and 2nd congress of oncology, Tehran, Iran (2006)
80. Eslamifar A, Aghakhani A, Ramezani A, et al. Epidemiology of Animal Bites in
Tehran.15th Iranian congress on infectious diseases and tropical medicine,
Tehran,Iran (2006)
81. Eslamifar A, Hamkar R, Ramezani A……and Aghakhani A. Hepatitis G virus
(HGV) Exposure in Dialysis Staff. 15th Iranian congress on infectious diseases
and tropical medicine, Tehran,Iran (2006)
82. Ramezani A , ………, Eslamifar A and Aghakhani A .YMDD mutants in
patients with chronic hepatitis B before treatment are not selected by
lamivudine.15th Iranian congress on infectious diseases and tropical medicine,
Tehran,Iran (2006)
83. Eslamifar A, Hamkar R, Ramezani A ……and Aghakhani A. Exposure to
Hepatitis GB Virus in Patients on Maintenance Hemodialysis. 15th Iranian
congress on infectious diseases and tropical medicine, Tehran, Iran (2006)
84. Ramezani A, Eslamifar A….Factors influencing to hepatitis B virus vaccination
in hemodialysis patients. XLIII ERA-EDTA Congress(Glasgow, United Kingdom,
July 15-18,( 2006)
85. Ramezani A, Eslamifar A,….Frequency of Hepatitis G infection among Iranian
blood donors.12th international congress on infectious diseases, Lisbon
,Portugal(2006)
86. Ramezani A, …Vancomycin resistant enterococci fecalis in clinical
specimen12th international congress on infectious diseases, Lisbon,
Portugal(2006)
36
87. Ramezani A, Eslamifar A,…Assessment of blood mercury levels in infants
exposed to vaccines containing thiomersal. 2nd international congress on
infectious and tropical diseases in Oman( 2006)
88. Ramezani A., Eslamifar A…Efficacy of hepatitis B vaccination schedule and
comparing to complete regimen hemodialysis patients of Iran.12th international
congress on infectious diseases, Lisbon , Portugal(2006)
89. Panel about Hepatitis in 5th midyear conference of infectious diseases Babolsar 1-
2 Nov (2006).
90. Panel about antimicrobial resistance in 5th midyear conference of infectious
diseases Babolsar 1-2 Nov (2006)
91. Ramezani A, Mohraz M, Banifazl M. Epidemiological situation of HIV/AIDS
patients in Iran. 10th European AIDS Conference/EACS. Nov. 17-20. (2005)
92. Rahmani H, Gachkar L, Ramezani A. HCV and HBV co-infection in HIV1
infected patients in Tehran (Iran).10th European AIDS Conference/EACS, Nov.
17-20. (2005)
93. Ramezani A, Mohraz M, Banifazl M. Frequency of vancomycin resistant
Enterococci faecium in hospitals of Tehran. 4th International Meeting on
Antimicrobial Chemotherapy in Clinical Practices Santa Margrita Portophino,
Nov. 10-12. (2005)
94. Ramezani A, Mohraz M, Banifazl M. Molecular epidemiology of vancomycin
resistant Enterococci fecium in Iran during 2000-2003. 4th International Meeting
on Antimicrobial Chemotherapy in Clinical Practices Santa Margrita Portophino,
Nov. 10-12, (2005)
37
95. Gachkar L, Ramezani A, Eslamifar A, Hamkar R, Khoshbaten M, Hazrati M.
Frequency of Hepatitis G infection among Iranian blood donors. 14th Congress of
Infectious Disease, Dec. 17-21. (2005)
96. Ramezani Amitis, Eslamifar Ali, …. Factors influencing to hepatitis B
vaccination response in hemodialysis patients of Tehran (Iran). 14th Congress of
Infectious Disease, Dec. 17-21. (2005)
97. Roshan M.R, Mohraz M, Ramezani A, Haji Ahmadi M and Velayati
A.A Efficacy of gentamycine plus doxycycline versus Streptomycin plus
doxycyline. International research conference for disclosure brucellosis small
rominants and humans. Macedonia, Nov. 28-30. (2005)
98. Lecture about nosocomial infection in Midyear Conference of Infectious Diseases
Babolsar, Sep. 27-29, (2005)
99. Panel about AIDS in 14th Congress of Infectious Diseases. Dec. 17-21, (2005)
100. Lecture about vaccination in Midyear Conference of Infectious Diseases
(2004)
101. Speech about vaccination and bites for General physician in Shaheed Beheshti
University (2004)
102. Panel about AIDS, Hepatitis, IDU, in 13th Congress of Infectious Diseases
(2004)
103. Rates of scar failure in children vaccinated with BCG. 13th Congress of
Infectious Diseases (2004)
104. Eslamifar A, Ramezani A, Nazgooie F, Mafakheri M, Hosseini Z Naseri M.R.
Situation of MR vaccination on mass campaign project in persons referred to
Institute Pasteur of Iran. 12th Congress of Infectious Diseases.(2003)
38
105. Babaiei M.R, Ramezani A. Effectiveness of Ethanol concentration as an
effective material for shortness Growth of M. Tuberculosis in culture. 11th
Congress of Infectious Diseases.(2002)
106. Babaiei M.R, Ramezani A. Effectiveness of Ethanol concentration on
resistant M. Tuberculosis in vitro. 11th Congress of Infectious Diseases.(2002)
107. Speech about urinary tract infection in Midyear Conferences of Infectious
Diseases (2002)
108. Babaei A, Ramezani A, Banifazl M. Study of garlic effectiveness on resistant
M. Tb. 11th Congress of Infectious Diseases.(2002)
109. Lecture about pneumonia for general physician in Babol University (2001)
110. Ramezani A, Karami A, Banifazl M. Complications of Anti tuberculosis
drugs in 1000 tuberculosis patients in Imam Khomeini Hospital (Tehran) (1991-
1997). 9th Iranian Congress on Infectious Disease, Jan. 14-18.(2001)
111. Ramezani A, Karami A, Banifazl M, Survey side effects of antituberculosis
drugs in 1000 out patient and inpatient tuberculosis patients in Imam Khomeini
Hospital of Tehran from 1992-1998. 9th Iranian Congress on Infectious Disease,
Jan. 14-18.(2001)
112. Ramezani A, Babaiei M.R, …. Epidemiological characteristics (primary
resistancy, failure, cure, conversion rate …) in tuberculosis patients referred to
Pasteur Institute of Iran. 9th Congress of Infectious Diseases.(2000)
113. Hadizadeh A.R, Karimi A, Babaiei M.R, Ramezani A. Evaluation relation of
age & clinical manifestation in patients suspicious to tuberculosis in Pasteur
Institute of Iran (1999-2000). 9th Congress of Infectious Disease.(2000)
39
114. Ahangari F, Ramezani A, Prevalence of sensorineural hearing loss due to
bacterial meningitis and factors associated in Tehran University (1997-1998). 9th
Congress of Infectious Diseases.(2000)
115. Etemadi G, Ramezani A, Ghazisaiedi K. Antimicrobial resistancy of bacteria
isolated from intestinal infection in patients referred to university of Health
between (1978-1991). 8th Congress of Infectious Diseases.(1999)
116. Bacteriology testing in tuberculosis patients features, risk factors and
prognosis. 8th Congress of Infectious Diseases (1999)
117. Ramezani A, Saghari H, Ghazisaedi K .Retrospective survey on the enteric
bacterial pathogens in patients referred to university of Health between1978-1991.
8th Congresses of Infectious Diseases.(1999)
118. Drug resistant tuberculosis and clinical outcome in patients in Tehran. 8th
Congress of Infectious Diseases (1999)
119. Ramezani A, Banifazl M. Survey 88 cases of infected abortion. 8th Congress
of Infectious Diseases.(1999)
Teaching course:
Infectious disease courses for M.Sc. and PhD students
Awards:
• Winner of Tehran University Book Award (1380)
• Best assistant professor of Pasteur institute of Iran (1389)
Gene Patents:
• 42 HIV gene in Gen Bank NCBI
40
• 21 HPV gene in Prostate cancer in Gen Bank NCBI
• 8 HBV gene in occult HBV infections in Gen Bank NCBI
• 40 HBV gene in hepatocellular carcinoma in Gen Bank NCBI
• 10 HGV gene in HIV infected patients in Gen Bank NCBI
• 34 HPV gene in esophageal cancer in Gen Bank NCBI